semaglutide 1.5 mg 5mg — Selective GLP-1 Receptor Agonist — Research Peptide – Prime Labs and a shorter life GLP-1 (S) - Simon's Compounding

That leads to five serious challenges for self-funded employers: High discontinuation rates

CBC (complete blood count): Gives a broad view of your overall health and helps flag infections or inflammation

Notably, older adults with obesity and preserved baseline muscle mass represent a particularly understudied phenotype, and dedicated studies are needed to determine whether this subgroup may differentially benefit from the muscle quality improvements associated with GLP-1 RA therapy

A dozen ounces above or below won't make a huge difference

2016a;39:157986

The campaign is currently under review by the TGA and a warning specifically targeted at those who promote semaglutide remains on the regulators website, where it reminds advertisers and social media influencers that advertising prescription medications to the public remains prohibited by law